“…The PVN and surrounding periventricular structures also contain the cell bodies of parvocellular oxytocinergic neurons that project to extra-hypothalamic brain areas (i.e., medial preoptic area, ventral tegmental area, hippocampus, amygdala, septum, bed nucleus of the stria terminalis, medulla oblongata, and spinal cord) (see [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]). Since their discovery in the 1980s (see [ 14 , 15 ]), these central oxytocinergic neurons have been involved in numerous central functions, i.e., memory; learning; affiliative and socio-sexual behaviors, from erectile function to copulatory behavior; yawning, and many others, from the control of pain and feeding behavior to drug dependence (see [ 3 , 4 , 5 , 6 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ]). In the last fifteen years, there have been many reports that have appeared and that are still appearing that have reported the effects of intranasal oxytocin, a delivery route believed to allow the crossing of the blood–brain barrier by the peptide, which can then reach and act at the level of the central nervous system (see [ 25 ]).…”